부산대학교 도서관

Mo J; Zaremba A; Inderjeeth AJ; El Zeinaty P; Li A; Wicky A; Della Marta N; Marqueste CG; Bohne AS; Matias M; McNamee N; Festino L; Chen C; Ch'ng S; van Akkooi ACJ; Meda LD; Park JJ; Ascierto PA; Hauschild A; Lee JH; Grob JJ; Mangana J; Guminski A; Michielin O; Xu W; Lebbe C; Sandhu S; Zimmer L; Menzies AM; Lo SN; Long GV; Carlino MS; da Silva IP

European Journal of Cancer. 217:115254

Connors, K.; Williamson, A.; Bai, X.; Andhale, A.; Shaheen, A.; Grieco, C.; d'Arienzo, P.; Mina, F.; Czapla, J.; Lawless, A.; Bongiovanni, E.; Santaniello, U.; Zappi, H.; Dulak, D.; Li, C.; Si, L.; Ubaldi, M.; Yamazaki, N.; Ogata, D.; Johnson, R.; Park, B.; Jung, S.; Madonna, G.; Hochherz, J.; Umeda, Y.; Nakamura, Y.; Gebhardt, C.; Festino, L.; Capone, M.; Ascierto, P.A.; Johnson, D.B.; Lo, S.N.; Long, G.V.; Menzies, A.M.; Namikawa, K.; Mandala, M.; Guo, J.; Najjar, Y.G.; Haydon, A.; Quaglino, P.; Boland, G.M.; Sullivan, R.J.; Furness, A.J.; Plummer, R.; Menendez, M.; Gupta, A.; Serra, P.; Ali, N.; Cooksley, T.; Flaherty, K.; Lorigan, P.; Lee, R.

EJC Skin Cancer. 3

Mallardo D.; Sparano F.; Vitale M. G.; Trojaniello C.; Fordellone M.; Cioli E.; Esposito A.; Festino L.; Mallardo M.; Vanella V.; Facchini B. A.; De Filippi R.; Meinardi P.; Ottaviano M.; Caraco C.; Simeone E.; Ascierto P. A.

Cancer Immunol Immunother

Mallardo, D.; Fordellone, M.; Bailey, M.; White, A.; Simeone, E.; Festino, L.; Vanella, V.; Trojaniello, C.; Vitale, M.G.; Ottaviano, M.; Sparano, F.; Facchini, B.A.; Cavalcanti, E.; Church, S.; Caracò, C.; Cesano, A.; Warren, S.; Chiodini, P.; Ascierto, P.A.

EJC Skin Cancer. 2

Guida, M. ; Strippoli, S. ; Maule, M. ; Quaglino, P. ; Ramondetta, A. ; Chiaron Sileni, V. ; Antonini Cappellini, G. ; Queirolo, P. ; Ridolfi, L. ; Del Vecchio, M. ; Cocorocchio, E. ; Di Giacomo, A.M. ; Festino, L. ; Merelli, B. ; Occelli, M. ; Brugnara, S. ; Minisini, A. ; Sava, S. ; Tommasi, S. ; De Summa, S.

In ESMO Open April 2021 6(2)

Madonna, G; Masucci, GV; Capone, M; Mallardo, D; Grimaldi, AM; Simeone, E; Vanella, V; Festino, L; Palla, M; Scarpato, L

CANCERS. 13(16):4164-4164

Mo, J.; Zaremba, A.; Inderjeeth, A-J.; El Zenaity, P.; Li, A.; Wicky, A.; Della Marta, N.; Marqueste, C. Gaudy; Bohne, A-S.; Festino, L.; Chen, C.; Lo, S. N.; Guminski, A.; Michielin, O. A.; Xu, W.; Lebbe, C.; Sandhu, S. K.; Zimmer, L.; Carlino, M. S.; Da Silva, I. Pires

ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS924-pS925, 2p. Supplement: 7

Mallardo D; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Fordellone M; Salute Mentale e Fisica e Medicina Preventiva, University of Campania Luigi Vanvitelli, Napoli, Italy.; Bailey M; Research and Development, NanoString Technologies Inc, Seattle, Washington, USA.; White A; Research and Development, NanoString Technologies Inc, Seattle, Washington, USA.; Simeone E; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Festino L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Vanella V; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Trojaniello C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Vitale MG; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Ottaviano M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Capone M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Costa C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Ingenito M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Sparano F; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Facchini BA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Cavalcanti E; Division of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy.; De Filippi R; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.; Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy.; Cesano A; ESSA Pharma, South San Francisco, California, USA.; Warren S; ESSA Pharma, South San Francisco, California, USA.; Chiodini P; Salute Mentale e Fisica e Medicina Preventiva, University of Campania Luigi Vanvitelli, Napoli, Italy.; Budillon A; Scientifc Directorate, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy.; Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy paolo.ascierto@gmail.com.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Festino L; Botti G; Lorigan P; Masucci G; Hipp J; Horak C; Melero I; Ascierto P

Festino, L, Botti, G, Lorigan, P, Masucci, G V, Hipp, J D, Horak, C, Melero, I & Ascierto, PA 2016, 'Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?', Drugs, vol. 76, no. 9, pp. 925-945. https://doi.org/10.1007/s40265-016-0588-x

Cantini L; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Labcorp Drug Development Inc, Princeton, NJ, USA.; Paoloni F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Pecci F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Spagnolo F; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy.; Genova C; Academic Medical Oncology Unit, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.; Tanda ET; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy.; Aerts S; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Rebuzzi SE; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Fornarini G; Medical Oncology Unit 1, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Zoratto F; UOC Oncologia, Ospedale Santa Maria Goretti, Latina, Italy.; Fancelli S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.; Lupi A; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Della Corte CM; Department of Precision Medicine, University of Campania, Italy.; Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.; Bennati C; S Maria delle Croci Hospital, AUSL della Romagna, Ravenna, Italy.; Ortega C; Oncology, Asl Cn2, Ospedale Michele e Pietro Ferrero, Verduno, Italy.; Atzori F; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.; Piovano PL; Oncology Unit, Azienda Ospedaliera 'SS. Antonio e Biagio e C. Arrigo', Alessandria, Italy.; Orciuolo C; Istituto di ricovero e cura a carattere scientific (IRCCS), National Cancer Institute Regina Elena, Rome, Italy.; De Tursi M; Department of Innovative Technologies in Medicine and Dentistry, University G. D'Annunzio, Chieti-Pescara, Italy.; Ghidini M; Oncology Unit, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.; Botticelli A; Medical Oncology Unit A, Policlinico Umberto I, Radiological, Oncological, Pathological Sciences Department, Sapienza University of Rome, Italy.; Scagnoli S; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy.; Belluomini L; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.; Leporati R; Medical Oncology, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy.; Veccia A; Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro 1, Trento, Italy.; Di Giacomo AM; Center for Immuno-Oncology, University of Siena, University Hospital of Siena, Siena, Italy.; Festino L; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy.; Cortinovis D; SC Oncologia Medica ASST H S Gerardo, Monza, Italy.; Acquati M; SC Oncologia Medica ASST H S Gerardo, Monza, Italy.; Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di ricovero e cura a carattere scientific (IRCCS), Rome, Italy.; Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy.; Tucci M; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy.; Sergi MC; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy.; Garutti M; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.; Puglisi F; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.; Department of Medicine (DAME), University of Udine, Udine, Italy.; Manglaviti S; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy.; Citarella F; Department of Medical Oncology, Campus Bio-Medico University, Rome, Italy.; Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.; Rijavec E; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy.; Lo Russo G; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy.; Santini D; UOC Oncologia Medica Territoriale, Sapienza Università, Polo Pontino, Rome, Italy.; Addeo A; Oncology Department, University Hospital Geneva, Geneva, Switzerland.; Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, and Medical Oncology Unit, Careggi University Hospital, Florence, Italy.; Indini A; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy.; Rocchi MBL; Biomolecular Sciences Department, University of Urbino, Urbino, Italy.; Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.; Grossi F; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, University of insubria, Varese, Italy.; Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy.; Aerts JGJV; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Berardi R; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Festino L; Fabozzi A; Manzo A; Gambardella V; Martinelli E; Troiani T; De Vita F; Orditura M; Ciardiello F; Morgillo F

Cancer Management and Research, Vol 2013, Iss default, Pp 49-55 (2013)

MORGILLO, Floriana; SASSO, Ferdinando Carlo; Della Corte CM; Festino L; Manzo A; MARTINELLI, Erika; TROIANI, Teresa; CAPUANO, Annalisa; CIARDIELLO, Fortunato

Expert Opinion on Investigational Drugs. 22:1401-1409

MORGILLO, Floriana; DE VITA, Ferdinando; Antoniol G; ORDITURA, Michele; Auriemma PP; Diadema MR; LIETO, Eva; Savastano B; Festino L; Laterza MM; Fabozzi A; Ventriglia J; Petrillo A; CIARDIELLO, Fortunato; BARBARISI, Alfonso; IOVINO, Francesco

Current Oncology
Volume 20
Issue 4
Pages 1380-288

Cristinziano L; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Modestino L; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Capone M; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Madonna G; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Mallardo D; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Giannarelli D; Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.; D'Angelo G; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Ferrara AL; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Institute of Experimental Endocrinology and Oncology, Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS), National Research Council (CNR), Naples, Italy.; Loffredo S; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Institute of Experimental Endocrinology and Oncology, Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS), National Research Council (CNR), Naples, Italy.; Varricchi G; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Institute of Experimental Endocrinology and Oncology, Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS), National Research Council (CNR), Naples, Italy.; Vanella V; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Festino L; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Ascierto PA; Melanoma, Cancer Immunotherapy, and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.; Galdiero MR; Department of Translational Medical Sciences (DiSMeT), University of Naples Federico II, Naples, Italy.; Center for Basic and Clinical Immunology Research, Interdipartimental Center for basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy.; Institute of Experimental Endocrinology and Oncology, Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS), National Research Council (CNR), Naples, Italy.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Granata V; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy. v.granata@istitutotumori.na.it.; Simonetti I; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy.; Fusco R; Medical Oncology Division, Igea SpA, Naples, Italy.; Setola SV; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy.; Izzo F; Hepatobiliary Surgical Oncology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia',, Via Mariano Semmola, Naples, Italy.; Scarpato L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Vanella V; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Festino L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Simeone E; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Petrillo A; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy.

Publisher: Springer Milan Country of Publication: Italy NLM ID: 0177625 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1826-6983 (Electronic) Linking ISSN: 00338362 NLM ISO Abbreviation: Radiol Med Subsets: MEDLINE

C Costanzo; A. Ianieri; M. Conter; L. Pennisi; P. Di Ciccio; A. Vergara; A.R Festino

Italian Journal of Food Safety, Vol 1, Iss 8, Pp 13-17 (2013)

Borzillo, V.; Di Franco, R.; Falivene, S.; Martino, A.; Ravo, V.; Totaro, G.; Giugliano, F.M.; Ascierto, P.A.; Grimaldi, A.M.; Festino, L.; Simeone, E.; Vanella, V.; Cammarota, F.; Giannarelli, D.; Muto, P.

Radiotherapy and Oncology. 123:S389-S390

Bai X; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.; Massachusetts General Hospital, USA.; Shaheen A; Newcastle University Centre for Cancer, UK.; Grieco C; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.; d'Arienzo PD; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Mina F; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Czapla JA; Massachusetts General Hospital, USA.; Lawless AR; Massachusetts General Hospital, USA.; Bongiovanni E; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.; Santaniello U; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.; Zappi H; Alfred Health, Australia.; Dulak D; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Williamson A; The Christie NHS Foundation Trust, Manchester, UK.; Lee R; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, UK.; Gupta A; The Christie NHS Foundation Trust, Manchester, UK.; Li C; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.; Si L; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.; Ubaldi M; University of Perugia, Italy.; Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Ogata D; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Johnson R; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.; Park BC; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Jung S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Madonna G; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Hochherz J; Department of Dermatology, University Medical Center Hamburg-Eppendorf (UKE), University Skin Cancer Center, Hamburg, Germany.; Umeda Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.; Nakamura Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.; Gebhardt C; Department of Dermatology, University Medical Center Hamburg-Eppendorf (UKE), University Skin Cancer Center, Hamburg, Germany.; Festino L; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Capone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Lo SN; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney, North Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Long GV; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.; Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Mandala M; University of Perugia, Italy.; Guo J; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.; Lorigan P; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, UK.; Najjar YG; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Haydon A; Alfred Health, Australia.; Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.; Boland GM; Massachusetts General Hospital, USA.; Sullivan RJ; Massachusetts General Hospital, USA.; Furness AJS; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Plummer R; Newcastle University Centre for Cancer, UK.; Flaherty KT; Massachusetts General Hospital, USA.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Sandomenico, F.; De rosa, G.; Pizza, S.; Catalano, O.; Setola, S.; Simeone, E.; Festino, L.; Grimaldi, A.; Vanella, V.; Petrillo, A.; Ascierto, P.

European Journal of Cancer. 92:S22-S22

Taylor AM; Melanoma Institute Australia, The University of Sydney, Australia.; McKeown J; Melanoma Institute Australia, The University of Sydney, Australia.; Dimitriou F; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Jacques SK; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia.; Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany.; Allayous C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France.; Yeoh HL; Alfred Health, Melbourne, Australia.; Haydon A; Alfred Health, Melbourne, Australia.; Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Galea C; Melanoma Institute Australia, The University of Sydney, Australia.; Woodford R; Melanoma Institute Australia, The University of Sydney, Australia.; Kahler K; University Hospital (UKSH), Campus Kiel, Department of Dermatology, Kiel, Germany.; Hauschild A; University Hospital (UKSH), Campus Kiel, Department of Dermatology, Kiel, Germany.; Festino L; Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Schwarze JK; Department of Medical Oncology, Brussels, Belgium.; Neyns B; Department of Medical Oncology, Brussels, Belgium.; Wicky A; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Michielin O; Precision Oncology Center, Lausanne University Hospital, Switzerland.; Placzke J; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Johnson DB; Vanderbilt University Medical Center, Nashville, USA.; Lebbe C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France.; Dummer R; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Ascierto PA; Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy.; Lo S; Melanoma Institute Australia, The University of Sydney, Australia.; Long GV; Melanoma Institute Australia, The University of Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Australia; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia. Electronic address: alexander.menzies@sydney.edu.au.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE